Neurotherapeutics Ltd listed as finalists in Medilink East Midlands Awards

Neurotherapeutics Ltd has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022 in 3 categories:

• ONE TO WATCH - Awarded to a business that shows a great deal of potential
• START UP - Awarded to a newly established business which demonstrates exceptional promise for the future
• PARTNERSHIP BETWEEN ACADEMIA AND BUSINESS - Awarded to the company who demonstrate how the collaboration / partnership has or will enhance current service delivery or create new ways of delivering healthcare.

Neurotherapeutics Ltd  has been shortlisted for these prestigious awards which recognises and promotes the excellence that East and West Midlands companies are achieving at the leading edge of the Life Sciences sector.

The 2022 awards will take place in person and will be the first opportunity since the merger of the East and West Midlands Medilink regions for members and the Life Sciences community to gather together to celebrate and network.

50 entries submitted across the 8 categories will be assessed by a panel of experts from the Life Science sector to select the winners. A winner will be announced for both the East and West Midlands Regions.